<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35962348</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1129-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>The journal of headache and pain</Title><ISOAbbreviation>J Headache Pain</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study.</ArticleTitle><Pagination><StartPage>101</StartPage><MedlinePgn>101</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10194-022-01468-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The burden of post-coronavirus disease (COVID)-19 symptoms has been increasing and is of great concern in patients with pre-existing chronic medical conditions.This study aimed to delineate the post-COVID-19 neuropsychiatric symptoms among migraine patients compared to the non-migraine control group.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two groups, each of 204 COVID-19 survivors, were enrolled in the study after 3&#xa0;months of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, one group fulfilling the episodic migraine criteria and the other serving as a matching control group. Subjects were evaluated through an in-person interview for post-COVID-19 neuropsychiatric symptoms, including detailed headache patterns and severity, using the visual analogue scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Frequency of headache during the acute phase of COVID-19 was more frequent in migraine patients (OR&#x2009;=&#x2009;1.60, 95%CI&#x2009;=&#x2009;1.04-2.45, P-value&#x2009;=&#x2009;0.031). The reported significant post-COVID-19 neuropsychiatric symptoms in migraine patients compared to controls were fatigue (OR&#x2009;=&#x2009;1.662, 95%CI&#x2009;=&#x2009;1.064-2.596, P-value&#x2009;=&#x2009;0.025), anosmia/hyposmia (OR&#x2009;=&#x2009;2.06, 95%CI&#x2009;=&#x2009;1.164- 3.645, P-value&#x2009;=&#x2009;0.012), cacosmia (OR&#x2009;=&#x2009;2.663, 95%CI&#x2009;=&#x2009;1.145-6.195, P-value&#x2009;=&#x2009;0.019), depression (OR&#x2009;=&#x2009;2.259, 95%CI&#x2009;=&#x2009;1.284- 3.975, P-value&#x2009;=&#x2009;0.004), anxiety (OR&#x2009;=&#x2009;3.267, 95%CI&#x2009;=&#x2009;1.747- 6.108, P-value&#x2009;&#x2264;&#x2009;0.001), insomnia (OR&#x2009;=&#x2009;2.203, 95%CI&#x2009;=&#x2009;1.298- 3.739, P-value&#x2009;=&#x2009;0.003), and headache (OR&#x2009;=&#x2009;3.148, 95%CI&#x2009;=&#x2009;1.616-6.136, P-value&#x2009;=&#x2009;&#x2009;&#x2264;&#x2009;0.001).While there was no statistically significant difference between migraine patients and controls regarding the post-COVID-19 functional status score (P-value&#x2009;=&#x2009;0.102). The pattern of post-COVID-19 headache was reported as chronic headache transformation in 17.6% of the migraine group, with the median intensity rate being 5.5 and IQR (3-7). In the control group, 14% experienced chronic headache attributed to systemic viral infection with a median intensity rate of 2 and IQR (2-5), while 12% experienced a new daily persistent headache with a median intensity of 5 and IQR (1-6).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study highlighted the importance of follow-up migraine patients upon recovery from COVID-19 infection, being more vulnerable to post-COVID-19 symptoms.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Magdy</LastName><ForeName>Rehab</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmazny</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Department, Arabian Gulf University, Manama, Bahrain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soliman</LastName><ForeName>Shaimaa H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. shoshosoliman@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsebaie</LastName><ForeName>Eman H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Public Health and Community Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Sara H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Faculty of Medicine, Beni-Suef University, Beni- Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel Fattah</LastName><ForeName>Ali M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Hepatology, and Endemic Medicine, Faculty of Medicine, Beni-Suef University, Beni- Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Beni-Suef University, Beni- Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yassien</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Beni-Suef University, Beni-Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahfouz</LastName><ForeName>Noha A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsayed</LastName><ForeName>Radwa M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fathy</LastName><ForeName>Wael</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Surgical ICU and Pain Management, Beni-Suef University, Beni-Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Hamid</LastName><ForeName>Hoda M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Jehan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Surgical ICU and Pain Management, Beni-Suef University, Beni-Suef, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology department, Beni-Suef University, Beni-Suef, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Headache Pain</MedlineTA><NlmUniqueID>100940562</NlmUniqueID><ISSNLinking>1129-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008881" MajorTopicYN="Y">Migraine Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Headache</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Migraine</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric symptoms</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Authors have no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35962348</ArticleId><ArticleId IdType="pmc">PMC9372973</ArticleId><ArticleId IdType="doi">10.1186/s10194-022-01468-y</ArticleId><ArticleId IdType="pii">10.1186/s10194-022-01468-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lemh&#xf6;fer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C. The impact of Post-COVID-Syndrome on functioning &#x2013; results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol. 2021;16(1):45. doi: 10.1186/s12995-021-00337-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12995-021-00337-9</ArticleId><ArticleId IdType="pmc">PMC8495185</ArticleId><ArticleId IdType="pubmed">34620202</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB (2021) Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol 12. 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Callender LA, Curran M, Bates SM, Mairesse M, Weigandt J, Betts CJ (2020) The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19. Front Immunol 11. 10.3389/fimmu.2020.01991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437504</ArticleId><ArticleId IdType="pubmed">32903476</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamal DM, Ibrahim RA, Samaan SF. Post COVID-19 syndrome in a prospective cohort study of Egyptian patients. Egypt RheumatolRehab. 2022;49(1):12. doi: 10.1186/s43166-021-00104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43166-021-00104-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsan N, Goadsby PJ (2021) Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?. Front Hum Neurosci 15. 10.3389/fnhum.2021.646692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209296</ArticleId><ArticleId IdType="pubmed">34149377</ArticleId></ArticleIdList></Reference><Reference><Citation>Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, et al. Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat. 2010;6:81&#x2013;91. doi: 10.2147/ndt.s8467.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ndt.s8467</ArticleId><ArticleId IdType="pmc">PMC2854084</ArticleId><ArticleId IdType="pubmed">20396640</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, G&#xf3;mez-Mayordomo V (2021) The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study 41(13):1332&#x2013;41. 10.1177/03331024211020404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein M, Fathy W, Eid RA, Abdel-Hamid HM, Yehia A, Sheemy MS, et al. Relative frequency and risk factors of COVID-19 related headache in a sample of Egyptian population: a hospital-based study. Pain Med (Malden, Mass) 2021;22(9):2092&#x2013;2099. doi: 10.1093/pm/pnab020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnab020</ArticleId><ArticleId IdType="pmc">PMC7928553</ArticleId><ArticleId IdType="pubmed">33544857</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, G&#xf3;mez-Mayordomo V, Garc&#xed;a-Azor&#xed;n D, Palacios-Ce&#xf1;a D, Florencio LL, Guerrero AL, et al. Previous history of migraine is associated with fatigue, but not headache, as long-term post-COVID symptom after severe acute respiratory SARS-CoV-2 infection: a case-control study. Front Hum Neurosci. 2021;15:678472. doi: 10.3389/fnhum.2021.678472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2021.678472</ArticleId><ArticleId IdType="pmc">PMC8290894</ArticleId><ArticleId IdType="pubmed">34295230</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg (London, England) 2014;12(12):1495&#x2013;1499. doi: 10.1016/j.ijsu.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. COVID-19: Clinical care. 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH . Clinical management of COVID-19: Interim guidance. 2020.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Stay Up to Date with Your COVID-19 Vaccines. COVID-19. 2022. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html.</Citation></Reference><Reference><Citation>The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. 10.1177/0333102413485658.</Citation><ArticleIdList><ArticleId IdType="pubmed">23771276</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101&#x2013;1102. doi: 10.1001/jama.2015.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Terkawi AS, Abolkhair A, Didier B, Alzhahrani T, Alsohaibani M, Terkawi YS, et al. Development and validation of Arabic version of the douleur neuropathique 4 questionnaire. Saudi J Anaesth. 2017;11(Suppl 1):S31&#x2013;S39. doi: 10.4103/sja.SJA_97_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sja.SJA_97_17</ArticleId><ArticleId IdType="pmc">PMC5463565</ArticleId><ArticleId IdType="pubmed">28616002</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edition. Arlington: American Psychiatric Association; 2013.</Citation></Reference><Reference><Citation>Dautzenberg G, Lijmer J, Beekman A. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls. Int J Geriatr Psychiatry. 2020;35(3):261&#x2013;9. doi: 10.1002/gps.5227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5227</ArticleId><ArticleId IdType="pmc">PMC7028034</ArticleId><ArticleId IdType="pubmed">31650623</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Membrilla JA, Caronna E, Trigo-L&#xf3;pez J, Gonz&#xe1;lez-Mart&#xed;nez A, Layos-Romero A, Pozo-Rosich P, et al. Persistent headache after COVID-19: Pathophysioloy, clinic and treatment. Neurology Perspectives. 2021;1:S31&#x2013;S36. doi: 10.1016/j.neurop.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurop.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8669731</ArticleId><ArticleId IdType="pubmed">38620971</ArticleId></ArticleIdList></Reference><Reference><Citation>Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307&#x2013;315. doi: 10.1016/j.jns.2016.11.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.11.071</ArticleId><ArticleId IdType="pubmed">28017235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A, Brenner MJ, De Luca P, Albanese M, D'Ascanio L, Ralli M, et al. Olfactory dysfunction, headache, and mental clouding in adults with long-COVID-19: what is the link between cognition and olfaction? a cross-sectional study. Brain Sci. 2022;12(2):154. doi: 10.3390/brainsci12020154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12020154</ArticleId><ArticleId IdType="pmc">PMC8870047</ArticleId><ArticleId IdType="pubmed">35203918</ArticleId></ArticleIdList></Reference><Reference><Citation>Akt&#xfc;rk T, Tan&#x131;k N, Serin H, Sa&#xe7;mac&#x131; H, &#x130;nan LE. Olfactory bulb atrophy in migraine patients. Neurol Sci. 2019;40(1):127&#x2013;132. doi: 10.1007/s10072-018-3597-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3597-6</ArticleId><ArticleId IdType="pubmed">30280362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R, Gubbi S, Koch CA. COVID-19 and chronic fatigue syndrome: an endocrine perspective. J Clin Transl Endocrinol. 2022;27:100284. doi: 10.1016/j.jcte.2021.100284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A Paradigm for Post-Covid-19 Fatigue Syndrome Analogous to ME/CFS. Front Neurol. 2021;12. 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T, Fietsam AC, Deters JR, Bryant AD, Kamholz J. Post-COVID-19 fatigue: potential contributing factors. Brain Sci. 2020;10(12):1012. doi: 10.3390/brainsci10121012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10121012</ArticleId><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J, Cipolla-Neto J, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001;71(6):747&#x2013;51. doi: 10.1136/jnnp.71.6.747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.71.6.747</ArticleId><ArticleId IdType="pmc">PMC1737637</ArticleId><ArticleId IdType="pubmed">11723194</ArticleId></ArticleIdList></Reference><Reference><Citation>Peres MF, Zukerman E, Young WB, Silberstein SD. Fatigue in chronic migraine patients. Cephalalgia. 2002;22(9):720&#x2013;724. doi: 10.1046/j.1468-2982.2002.00426.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-2982.2002.00426.x</ArticleId><ArticleId IdType="pubmed">12421157</ArticleId></ArticleIdList></Reference><Reference><Citation>Attademo L, Bernardini F. Are dopamine and serotonin involved in COVID-19 pathophysiology? Eur J Psychiatry. 2021;35(1):62&#x2013;63. doi: 10.1016/j.ejpsy.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpsy.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7598536</ArticleId><ArticleId IdType="pubmed">33162632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltenboeck A, Harmer C. The neuroscience of depressive disorders: A brief review of the past and some considerations about the future. Brain Neurosci Adv. 2018;2:1&#x2013;6. doi: 10.1177/2398212818799269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2398212818799269</ArticleId><ArticleId IdType="pmc">PMC7058215</ArticleId><ArticleId IdType="pubmed">32166149</ArticleId></ArticleIdList></Reference><Reference><Citation>Deen M, Christensen CE, Hougaard A, Hansen HD, Knudsen GM, Ashina M. Serotonergic mechanisms in the migraine brain - a systematic review. Cephalalgia. 2017;37(3):251&#x2013;264. doi: 10.1177/0333102416640501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102416640501</ArticleId><ArticleId IdType="pubmed">27013238</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson G, Reiter RJ. Melatonin: Roles in influenza, Covid-19, and other viral infections. Rev Med Virol. 2020;30(3):e2109-e. doi: 10.1002/rmv.2109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2109</ArticleId><ArticleId IdType="pmc">PMC7235470</ArticleId><ArticleId IdType="pubmed">32314850</ArticleId></ArticleIdList></Reference><Reference><Citation>Liampas I, Siokas V, Brotis A, Vikelis M, Dardiotis E. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis. Headache: The Journal of Head and Face Pain. 2020;60(7):1273&#x2013;99. 10.1111/head.13828.</Citation><ArticleIdList><ArticleId IdType="pubmed">32352572</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios. Headache. 2021;61(8):1277&#x2013;80. doi: 10.1111/head.14197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14197</ArticleId><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. 2021;28(11):3820&#x2013;5. 10.1111/ene.15040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Layos-Romero A. Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. 2022;42(8):804&#x2013;9. 10.1177/03331024211068074.</Citation><ArticleIdList><ArticleId IdType="pubmed">35166156</ArticleId></ArticleIdList></Reference><Reference><Citation>Yapici-Eser H, Koroglu YE, OztoP-Cakmak O, Keskin O, Gursoy A, Gursoy-Ozdemir Y. Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions. Front Hum Neurosci. 2021;15:656313. doi: 10.3389/fnhum.2021.656313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2021.656313</ArticleId><ArticleId IdType="pmc">PMC8021734</ArticleId><ArticleId IdType="pubmed">33833673</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, Takeshima T, Igarashi H, Imai N, Danno D, Yamamoto T, et al. Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study. J Headache Pain. 2021;22(1):53. doi: 10.1186/s10194-021-01263-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01263-1</ArticleId><ArticleId IdType="pmc">PMC8182734</ArticleId><ArticleId IdType="pubmed">34098873</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hashel JY, Ismail II. Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study. J Headache Pain. 2020;21(1):115. doi: 10.1186/s10194-020-01183-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-01183-6</ArticleId><ArticleId IdType="pmc">PMC7513457</ArticleId><ArticleId IdType="pubmed">32972360</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin JH, Lin YK. Prevalence and association of lifestyle and medical-, psychiatric-, and pain-related comorbidities in patients with migraine: a cross-sectional study. 2021;61(5):715-26. 10.1111/head.14106.</Citation><ArticleIdList><ArticleId IdType="pubmed">33818765</ArticleId></ArticleIdList></Reference><Reference><Citation>Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428. doi: 10.1136/jnnp.2009.192492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.192492</ArticleId><ArticleId IdType="pubmed">20164501</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86&#x2013;92. doi: 10.1007/s11916-011-0233-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-011-0233-z</ArticleId><ArticleId IdType="pmc">PMC3258393</ArticleId><ArticleId IdType="pubmed">22083262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Cho S-J, Kim W-J, Yang KI, Yun C-H, Chu MK. Impact of migraine on the clinical presentation of insomnia: a population-based study. J Headache Pain. 2018;19(1):86. doi: 10.1186/s10194-018-0916-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-018-0916-5</ArticleId><ArticleId IdType="pmc">PMC6755581</ArticleId><ArticleId IdType="pubmed">30218221</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung WF, Chung KF, Wong CY. Relationship between insomnia and headache in community-based middle-aged Hong Kong Chinese women. J Headache Pain. 2010;11(3):187&#x2013;195. doi: 10.1007/s10194-010-0199-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10194-010-0199-y</ArticleId><ArticleId IdType="pmc">PMC3451911</ArticleId><ArticleId IdType="pubmed">20186559</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton RB, Fanning KM, Buse DC, Martin VT, Reed ML, Manack Adams A, et al. Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2018;58(7):933&#x2013;47. doi: 10.1111/head.13342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13342</ArticleId><ArticleId IdType="pubmed">30024028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J-H, Tsai S-J, Liu T-C, Chen Y-C, Lai J-T. Association of tinnitus and other cochlear disorders with a history of migraines. JAMA Otolaryngology-Head &amp; Neck Surgery. 2018;144(8):712&#x2013;717. doi: 10.1001/jamaoto.2018.0939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2018.0939</ArticleId><ArticleId IdType="pmc">PMC6143001</ArticleId><ArticleId IdType="pubmed">30003226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>